New safety standards for anticoagulant therapy in the treatment of atrial fibrillation

The review article study the safety and efficacy of using direct acting oral anticoagulants: thrombin inhibitor dabigatran etexilate and inhibitors Xa of the blood clotting factor apixaban, rivaroxaban and edoxaban compared with the vitamin K antagonist warfarin in patients with non-valvular atrial...

Full description

Bibliographic Details
Main Author: E. I. Baranova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2018-11-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3080